- Home
- OSCR vs BLCO Comparison
OSCR vs BLCO Comparison
Compare OSCR & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSCR
- BLCO
- Stock Information
- Founded
- OSCR 2012
- BLCO 1853
- Country
- OSCR United States
- BLCO Canada
- Employees
- OSCR N/A
- BLCO N/A
- Industry
- OSCR Accident &Health Insurance
- BLCO Ophthalmic Goods
- Sector
- OSCR Finance
- BLCO Health Care
- Exchange
- OSCR Nasdaq
- BLCO Nasdaq
- Market Cap
- OSCR 4.7B
- BLCO 5.2B
- IPO Year
- OSCR 2021
- BLCO 2022
- Fundamental
- Price
- OSCR $18.13
- BLCO $16.16
- Analyst Decision
- OSCR Sell
- BLCO Hold
- Analyst Count
- OSCR 7
- BLCO 14
- Target Price
- OSCR $14.86
- BLCO $16.69
- AVG Volume (30 Days)
- OSCR 17.8M
- BLCO 537.4K
- Earning Date
- OSCR 11-06-2025
- BLCO 10-29-2025
- Dividend Yield
- OSCR N/A
- BLCO N/A
- EPS Growth
- OSCR N/A
- BLCO N/A
- EPS
- OSCR N/A
- BLCO N/A
- Revenue
- OSCR $11,288,628,000.00
- BLCO $4,976,000,000.00
- Revenue This Year
- OSCR $33.80
- BLCO $8.12
- Revenue Next Year
- OSCR N/A
- BLCO $5.81
- P/E Ratio
- OSCR N/A
- BLCO N/A
- Revenue Growth
- OSCR 37.38
- BLCO 6.23
- 52 Week Low
- OSCR $11.20
- BLCO $10.45
- 52 Week High
- OSCR $23.80
- BLCO $20.71
- Technical
- Relative Strength Index (RSI)
- OSCR 57.85
- BLCO 59.04
- Support Level
- OSCR $12.64
- BLCO $14.44
- Resistance Level
- OSCR $14.89
- BLCO $16.81
- Average True Range (ATR)
- OSCR 1.11
- BLCO 0.60
- MACD
- OSCR 0.40
- BLCO 0.02
- Stochastic Oscillator
- OSCR 93.91
- BLCO 72.15
About OSCR Oscar Health Inc.
Oscar Health Inc is a health insurance company. The company provides various insurance plans for individuals, families, and employees. Also, the company provides virtual care, doctor support, scheduling appointments, and other related services. The company provides plans in the Medicare Advantage program to adults who are age 65 and older and eligible for traditional Medicare but who instead select coverage through a private market plan.
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.